Santen Pharmaceutical
4536.T
$8.96
Share price
-1.54%
Change (1 day)
18.99%
Change (1 year)
Categories
Santen Pharmaceutical (4536.T) - Cash on Hand
Cash on Hand as of December 2022 : $0.47 B
According to Santen Pharmaceutical
's latest financial reports the company has $0.47 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Santen Pharmaceutical - Cash on Hand chart (from 2009 to 2022)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-03-31 | $0.69 B | 20.18% |
| 2021-03-31 | $0.57 B | -32.4% |
| 2020-03-31 | $0.85 B | 32.84% |
| 2019-03-31 | $0.64 B | -2.42% |
| 2018-03-31 | $0.65 B | 36.75% |
| 2017-03-31 | $0.47 B | -46.1% |
| 2016-03-31 | $0.89 B | 61.61% |
| 2015-03-31 | $0.55 B | -26.03% |
| 2014-03-31 | $0.74 B | 13.44% |
| 2013-03-31 | $0.65 B | -31.12% |
| 2012-03-31 | $0.95 B | 0.44% |
| 2011-03-31 | $0.94 B | 35.1% |
| 2010-03-31 | $0.70 B | 43.27% |
| 2009-03-31 | $0.49 B | -4.69% |
| 2008-03-31 | $0.51 B | 18.26% |
| 2007-03-31 | $0.43 B | 11.85% |
| 2006-03-31 | $0.38 B | 26.25% |
| 2005-03-31 | $0.30 B |